Publications by authors named "Emily Mears"

Claim this Profile
S
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, Euphemia Leung, Emily R Mears

Antiviral Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.
Rohan Ameratunga, Emily Mears, Euphemia Leung, Russell Snell, See-Tarn Woon

Clin Exp Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful editing and maintenance of lactogenic gene expression in primary bovine mammary epithelial cells.
Janelle Moody, Emily Mears, Alexander J Trevarton, Marita Broadhurst, Adrian Molenaar

In Vitro Cell Dev Biol Anim· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of SpCas9-expressing bovine mammary epithelial cell lines.
Alexander J Trevarton, Emily R Mears, Janelle Moody, Thomas J Lopdell, Thaize Q Chometon

In Vitro Cell Dev Biol Anim· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Omic Huntington's Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis.
Emily R Mears, Renee R Handley, Matthew J Grant, Suzanne J Reid, Benjamin T Day

J Huntingtons Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection.
Rohan Ameratunga, See-Tarn Woon, Richard Steele, Russell Snell, Natalie Medlicott, Emily Mears

Expert Rev Clin Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
Rohan Ameratunga, Klaus Lehnert, Euphemia Leung, Davide Comoletti, Russell Snell, Emily Mears

N Z Med J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive intraspecies cryptic variation in an ancient embryonic gene regulatory network.
Yamila N Torres Cleuren, Chee Kiang Ewe, Kyle C Chipman, Emily R Mears, Cricket G Wood

Elife· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
Renee R Handley, Suzanne J Reid, Rudiger Brauning, Paul Maclean, Emily R Mears

Proc Natl Acad Sci U S A· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.
Emily Rose Mears, Farrokh Modabber, Robert Don, George E Johnson

PLoS Negl Trop Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis